Metoprolol succinate and Phenylbutazone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 3 people who take Metoprolol succinate and Phenylbutazone. Common interactions include cardiac failure among females.
The phase IV clinical study analyzes what interactions people who take Metoprolol succinate and Phenylbutazone have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Metoprolol succinate and Phenylbutazone together, and have interactions are studied.
What is Metoprolol succinate?
Metoprolol succinate has active ingredients of metoprolol succinate. It is used in high blood pressure. Currently, eHealthMe is studying from 61,556 Metoprolol succinate users.
What is Phenylbutazone?
Phenylbutazone has active ingredients of phenylbutazone. Currently, eHealthMe is studying from 260 Phenylbutazone users.
Number of Metoprolol succinate and Phenylbutazone reports submitted per year:
Common Metoprolol Succinate and Phenylbutazone drug interactions by gender *:
female:
- Cardiac failure
- Hypertensive crisis
- Pneumonia
- Upper gastrointestinal haemorrhage
- Cardiac failure congestive
- Coronary arterial stent insertion
- Coronary artery disease
- Hypotension
- Rash
male:
n/a
Common Metoprolol Succinate and Phenylbutazone drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Cardiac failure
- Hypertensive crisis
- Pneumonia
- Upper gastrointestinal haemorrhage
- Cardiac failure congestive
- Coronary arterial stent insertion
- Coronary artery disease
- Hypotension
- Rash
* Approximation only. Some reports may have incomplete information.
Do you take Metoprolol succinate and Phenylbutazone?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Metoprolol succinate side effects (61,556 reports)
- Phenylbutazone side effects (260 reports)
Common Metoprolol succinate drug interactions:
- Metoprolol succinate and Aspirin: 15,218 reports
- Metoprolol succinate and Lisinopril: 8,541 reports
- Metoprolol succinate and Furosemide: 7,861 reports
- Metoprolol succinate and Amlodipine: 7,451 reports
- Metoprolol succinate and Omeprazole: 6,921 reports
- Metoprolol succinate and Gabapentin: 5,711 reports
- Metoprolol succinate and Pantoprazole: 5,650 reports
- Metoprolol succinate and Vitamin d: 5,636 reports
- Metoprolol succinate and Metformin: 5,564 reports
- Metoprolol succinate and Simvastatin: 5,337 reports
Browse interactions between Metoprolol succinate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse interactions between Phenylbutazone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on metoprolol succinate and phenylbutazone (the active ingredients of Metoprolol succinate and Phenylbutazone, respectively), and Metoprolol succinate and Phenylbutazone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Metoprolol succinate and Phenylbutazone.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diphenhydramine Hydrochloride and Dipyridamole drug interaction - 3 seconds ago
- Somatuline Depot and Seizures - 4 seconds ago
- Paroxetine and Pomalidomide drug interaction - 7 seconds ago
- Morphine and Parkinsonism Aggravated - 35 seconds ago
- Tambocor and Haemoglobin Decreased - 45 seconds ago
- Lorcet-Hd and Remeron drug interaction - 48 seconds ago
- Advair Hfa and Onfi drug interaction - 51 seconds ago
- Mometasone Furoate and Indapamide drug interaction - 52 seconds ago
- Anastrozole and Neurodermatitis Aggravated - 56 seconds ago
- Ocrevus and Oesophagitis Aggravated - a minute ago